SURF
$5.24
Surface Oncology
($.39)
(6.93%)
SURF
Earnings Whisper ®
N/A
4th Quarter December 2021
Consensus:  ($0.15)
Revenue:  $30.00 Mil
Thursday
Feb 3
7:10 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when SURF reports earnings?
Beat
Meet
Miss

Where is SURF's stock price going from here?
Up
Flat
Down
Stock chart of SURF
Analysts
Summary of analysts' recommendations for SURF
Score
Grade
Pivots
Resistance
$5.99
$5.81
$5.53

$5.35

Support
$5.07
$4.89
$4.61
Tweet
Growth
Description
Surface Oncology, Inc. is a clinical-stage immuno-oncology company. It develops therapies for the treatment of cancer. The company's product pipeline includes CD47, CD73, SRF231, SRF373, SRF617, SRF388 and SRF231 which are in clinical stage. Surface Oncology is based in Cambridge, Massachusetts.